Gastroenterology Doctors in Weston, FL Accepting Medicare

9 Gastroenterology doctors found. Showing 1 - 9

Dr. Beverton R Moxey, M.D Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Cleveland Clinic Florida, Weston, FL 33331 Phone: 954-659-5646    Fax: 954-659-5647

Alison J Schneider, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-6039

Andrew (andrzej) Ukleja, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-5647

Dr. Roger Charles, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-6039

Dr. Adalberto Jose Gonzalez, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5488

Dr. Nicole Anil Palekar, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 210-691-0020

Daniel S Klein, D.O. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 877-463-2010

Fernando Castro-pavia, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-5647

Dr. Leyla V Maric, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5488

News Archive

Study reveals new mechanism underlying immune-cell activation

When antibody-producing immune cells encounter infectious pathogens for the first time, they engage a signal cascade to generate a massive activation signal within seconds.

Women, diabetics, dementia patients most likely to fall in 'doughnut hole'; Reform seeks to close coverage gap

Among elderly Americans, women and those with diabetes and dementia are most likely to find themselves in the Medicare Part D drug plan 'doughnut hole,' the coverage gap that occurs after a beneficiary has reached the annual coverage limit but hasn't spent enough on drugs to qualify for catastrophic coverage.

Innovation in immunization programs can mean better learning, sharing of information

In this Guardian "Global Development Professionals Network" blog post, Robert Steinglass, senior immunization adviser at John Snow, Inc., and immunization team leader for the USAID-funded Maternal and Child Health Integrated Program, writes about the importance of innovation to improving childhood immunization programs and health systems.

Sanofi's insulin glargine delays progression from pre-diabetes to T2DM

Sanofi presented results from the landmark ORIGIN trial (Outcome Reduction with Initial Glargine Intervention) at the American Diabetes Association 72nd Scientific sessions. The key findings showed that, compared to standard care, Lantus(insulin glargine [rDNA] injection) had no statistically significant positive or negative impact on cardiovascular (CV) outcomes versus standard care during the study period and that there was no association between insulin glargine use and increased risk of any cancer.

Merrion, Novo Nordisk enter Collaboration and Option agreement for GIPET technology

Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.

Read more Medical News

› Verified 6 days ago